Recent Comments

Comment RSS

Neurosurgery News and Research RSS Feed - Neurosurgery News and Research

UCH introduces RapidArc technology from Varian Medical Systems

20. November 2009 00:55
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. [More]

Smoking cigarettes leads to back pain and spine problems, show recent studies

19. November 2009 02:59
Smoking cigarettes not only contributes to lung cancer and emphysema, it also leads to back pain and spine problems, according to recent studies and observations from leading neurosurgeons in Chicago. [More]

Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease

18. November 2009 02:02
Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the U.S. [More]

Novel device may reduce ischemic stroke damage

18. November 2009 00:47
Stroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24. [More]

CONMED Linvatec produces the smallest Biocomposite Interference screw for fixation of ACL and PCL grafts

17. November 2009 08:54
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of new sizes of its Matryx™ Biocomposite Interference Screw. These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market today for primary fixation of ACL and PCL grafts. [More]

Posted in: Device / Technology News | Medical Procedure News | Medical Science News

Tags: , , ,

Mount Sinai School of Medicine to participate in Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease

17. November 2009 00:23
Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the U.S. [More]

Bullseye Anatomic Cruciate Reconstruction System released

16. November 2009 07:37
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee. [More]

Posted in: Device / Technology News

Tags: , , , , , , ,

New surgical technique may benefit brain injured athletes

16. November 2009 03:52
NFL players and other athletes who suffer serious or multiple concussions may benefit from ground-breaking research being conducted by scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center. The scientists are developing a surgical technique that involves hypothermia in specific regions of the brain. [More]

Posted in: Medical Procedure News

Tags: , , , , , , , , ,

Misonix inks a three-year distribution agreement with Xenith in Dubai

13. November 2009 10:43
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider. [More]

Posted in: Business / Finance | Device / Technology News

Tags: , , , ,

Mechanical ventilation damages lungs, says scientist

13. November 2009 03:53
As more Canadians are diagnosed with H1N1 influenza infection, some will be admitted to hospital. The most severely affected may be treated in the intensive care unit (ICU) and placed on a mechanical ventilator to help them breathe while they recover from the infection. [More]

Canadian researchers organize several clinical trials to find new treatments for H1N1 infection

12. November 2009 04:15
An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. [More]

New microscope is expected to improve accuracy of intraoperative diagnostics

11. November 2009 23:01
A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery. [More]

Posted in: Device / Technology News | Medical Science News | Medical Condition News

Tags: , , , , ,

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

11. November 2009 05:59
Anthony Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates in Charlotte, NC, has co-authored the first evidence-based, multidisciplinary treatment guidelines for brain metastases patients. These guidelines were recently presented at the Congress of Neurological Surgeons 2009 Annual Meeting in New Orleans, and were developed over the last year by a 20-member panel from various medical specialties. [More]

Posted in: Medical Condition News | Healthcare News

Tags: , , , , , , , ,

Men more likely to abandon partners diagnosed with cancer

11. November 2009 04:31
A woman is six times more likely to be separated or divorced soon after a diagnosis of cancer or multiple sclerosis than if a man in the relationship is the patient, according to a study that examined the role gender played in so-called "partner abandonment." The study also found that the longer the marriage the more likely it would remain intact. [More]

New technique to identify patients more likely to survive advanced melanoma

10. November 2009 00:26
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.